Search Results

There are 12719 results for: content related to: A trial of dextromethorphan in parkinsonian patients with motor response complications

  1. Non-NMDA receptor-mediated mechanisms are involved in levodopa-induced motor response alterations in parkinsonian rats

    Synapse

    Volume 36, Issue 4, 15 June 2000, Pages: 267–274, Concepció Marin, Anna Jimenez, Mercè Bonastre, Thomas N. Chase and Eduardo Tolosa

    Version of Record online : 27 APR 2000, DOI: 10.1002/(SICI)1098-2396(20000615)36:4<267::AID-SYN3>3.0.CO;2-Y

  2. Assessment of CYP2D6 and CYP2C19 activity in vivo in humans: A cocktail study with dextromethorphan and chloroguanide alone and in combination

    Clinical Pharmacology & Therapeutics

    Volume 66, Issue 6, December 1999, Pages: 582–588, Laurent Tennezé, Céline Verstuyft, Laurent Becquemont, Jean-Marie Poirier, Grant R. Wilkinson and Christian Funck-Brentano

    Version of Record online : 19 DEC 1999, DOI: 10.1053/cp.1999.v66.103401001

  3. Dextromethorphan

    Annals of the New York Academy of Sciences

    Volume 1139, Issue 1, October 2008, Pages: 402–411, Joseph A. Banken and Howell Foster

    Version of Record online : 6 OCT 2008, DOI: 10.1196/annals.1432.003

  4. Dextromethorphan

    Medical Toxicology of Drug Abuse: Synthesized Chemicals and Psychoactive Plants

    Donald G. Barceloux, Pages: 527–538, 2012

    Published Online : 2 FEB 2012, DOI: 10.1002/9781118105955.ch29

  5. You have free access to this content
    Assessment of the effect of dextromethorphan and ketamine on the acute nociceptive threshold and wind-up of the second pain response in healthy male volunteers

    British Journal of Clinical Pharmacology

    Volume 53, Issue 6, June 2002, Pages: 604–612, A. M. Hughes, J. Rhodes, G. Fisher, M. Sellers and J. W. Growcott

    Version of Record online : 24 JUN 2002, DOI: 10.1046/j.1365-2125.2002.01602.x

  6. Low doses of dextromethorphan have a beneficial effect in the treatment of neuropathic pain

    Fundamental & Clinical Pharmacology

    Volume 28, Issue 6, December 2014, Pages: 671–680, Véronique Morel, Gisèle Pickering, Monique Etienne, Amandine Dupuis, Anne-Marie Privat, Maryse Chalus, Alain Eschalier and Laurence Daulhac

    Version of Record online : 30 APR 2014, DOI: 10.1111/fcp.12076

  7. Dextromethorphan Abuse Leading to Assault, Suicide, or Homicide

    Journal of Forensic Sciences

    Volume 57, Issue 5, September 2012, Pages: 1388–1394, Barry K. Logan, Jillian K. Yeakel, Gary Goldfogel, Michael P. Frost, Greg Sandstrom and Dennis J. Wickham

    Version of Record online : 26 APR 2012, DOI: 10.1111/j.1556-4029.2012.02133.x

  8. Determination of cytochrome P450 3A4/5 activity in vivo with dextromethorphan N-demethylation

    Clinical Pharmacology & Therapeutics

    Volume 60, Issue 4, October 1996, Pages: 374–384, David R. Jones, J. Christopher Gorski, Barbara D. Haehner, Edward M. O'Mara Jr. and Stephen D. Hall

    Version of Record online : 1 OCT 1996, DOI: 10.1016/S0009-9236(96)90194-0

  9. Amantadine and other antiglutamate agents

    Movement Disorders

    Volume 17, Issue S4, July/August 2002, Pages: S13–S22,

    Version of Record online : 29 JUL 2002, DOI: 10.1002/mds.5557

  10. Polymorphic dextromethorphan metabolism: Co-segregation of oxidative O-demethylation with debrisoquin hydroxylation

    Clinical Pharmacology & Therapeutics

    Volume 38, Issue 6, December 1985, Pages: 618–624, B Schmid, J Bircher, R Preisig and A Küpfer

    Version of Record online : 2 DEC 1985, DOI: 10.1038/clpt.1985.235

  11. You have free access to this content
    Population pharmacokinetic modelling to assess the impact of CYP2D6 and CYP3A metabolic phenotypes on the pharmacokinetics of tamoxifen and endoxifen

    British Journal of Clinical Pharmacology

    Volume 78, Issue 3, September 2014, Pages: 572–586, Rob ter Heine, Lisette Binkhorst, Anne Joy M. de Graan, Peter de Bruijn, Jos H. Beijnen, Ron H. J. Mathijssen and Alwin D. R. Huitema

    Version of Record online : 21 AUG 2014, DOI: 10.1111/bcp.12388

  12. A validated SIM GC/MS method for the simultaneous determination of dextromethorphan and its metabolites dextrorphan, 3-methoxymorphinan and 3-hydroxymorphinan in biological matrices and its application to in vitro CYP2D6 and CYP3A4 inhibition study

    Biomedical Chromatography

    Volume 23, Issue 11, November 2009, Pages: 1131–1137, Marios Spanakis, Ioannis S. Vizirianakis, Maria Mironidou-Tzouveleki and Ioannis Niopas

    Version of Record online : 14 MAY 2009, DOI: 10.1002/bmc.1234

  13. Anti-dyskinetic mechanisms of amantadine and dextromethorphan in the 6-OHDA rat model of Parkinson’s disease: role of NMDA vs. 5-HT1A receptors

    European Journal of Neuroscience

    Volume 36, Issue 9, November 2012, Pages: 3224–3234, Melanie A. Paquette, Alex A. Martinez, Teresa Macheda, Charles K. Meshul, Steven W. Johnson, S. Paul Berger and Andrea Giuffrida

    Version of Record online : 3 AUG 2012, DOI: 10.1111/j.1460-9568.2012.08243.x

  14. You have free access to this content
    Honey for acute cough in children

    Evidence-Based Child Health: A Cochrane Review Journal

    Volume 9, Issue 2, June 2014, Pages: 401–444, Olabisi Oduwole, Martin M Meremikwu, Angela Oyo-Ita and Ekong E Udoh

    Version of Record online : 16 JUN 2014, DOI: 10.1002/ebch.1970

  15. The effect of dextromethorphan, alone or in combination with ibuprofen, on postoperative pain after minor gynaecological surgery

    Acta Anaesthesiologica Scandinavica

    Volume 44, Issue 7, August 2000, Pages: 873–877, S. Ilkjær, P. A. Nielsen, L. F. Bach, M. Wernberg and J. B. Dahl

    Version of Record online : 24 DEC 2001, DOI: 10.1034/j.1399-6576.2000.440715.x

  16. Developmental toxicity of dextromethorphan in zebrafish embryos/larvae

    Journal of Applied Toxicology

    Volume 31, Issue 2, March 2011, Pages: 157–163, Zheng Xu, Frederick E. Williams and Ming-Cheh Liu

    Version of Record online : 24 AUG 2010, DOI: 10.1002/jat.1576

  17. Polymorphism of dextromethorphan oxidation in South Indian subjects

    Clinical Pharmacology & Therapeutics

    Volume 66, Issue 2, August 1999, Pages: 193–200, Rao N.V.S. Mamidi, Shreeram Satyavageeswaran, Swaroopkumar V.S. Vakkalanka, Madhusudana R. Chaluvadi, Kasiram Katneni, Nataraj Brahmadevara, Govindadas Damodarram and Swaminathan Subramaniam

    Version of Record online : 5 AUG 1999, DOI: 10.1053/cp.1999.v66.99989

  18. The influence of CYP2D6 polymorphism and quinidine on the disposition and antitussive effect of dextromethorphan in humans

    Clinical Pharmacology & Therapeutics

    Volume 60, Issue 3, September 1996, Pages: 295–307, Deborah A. Capon, Felix Bochner, Nicole Kerry, Gerd Mikus, Catherine Danz and Andrew A. Somogyi

    Version of Record online : 15 SEP 1996, DOI: 10.1016/S0009-9236(96)90056-9

  19. You have free access to this content
    Dextromethorphan, chlorphenamine and serotonin toxicity: case report and systematic literature review

    British Journal of Clinical Pharmacology

    Volume 70, Issue 6, December 2010, Pages: 794–798, Andrew A. Monte, Ryan Chuang and Michael Bodmer

    Version of Record online : 11 NOV 2010, DOI: 10.1111/j.1365-2125.2010.03747.x

  20. Dextromethorphan: Enhancing its systemic availability by way of low-dose quinidine-mediated inhibition of cytochrome P4502D6

    Clinical Pharmacology & Therapeutics

    Volume 51, Issue 6, June 1992, Pages: 647–655, Ying Zhang, Margaret R Britto, Kristen L Valderhaug, Peter J Wedlund and Richard A Smith

    Version of Record online : 14 JUN 1992, DOI: 10.1038/clpt.1992.77